Oncothyreon Announces Presentations at Upcoming Investment Conferences in September 2012
SEATTLE, Aug. 29, 2012 /PRNewswire/ - Oncothyreon Inc. (Nasdaq: ONTY) announced today that Robert Kirkman , M.D., President and Chief Executive Officer, will be presenting at the following upcoming investment conferences in September.
Stifel Nicolaus 2012 Annual Healthcare Conference
Wednesday, September 5, 2012, at 3:15 p.m. Eastern time in Boston, MA
Rodman & Renshaw 14th Annual Healthcare Conference
Tuesday, September 11, 2012, at 10 a.m. Eastern time in New York, NY
A live and archived webcast of each presentation will be accessible by visiting the Oncothyreon website www.oncothyreon.com under the "News & Events" section.
About Oncothyreon
Oncothyreon is a biotechnology company specializing in the development of innovative therapeutic products for the treatment of cancer. Oncothyreon's goal is to develop and commercialize novel synthetic vaccines and targeted small molecules that have the potential to improve the lives and outcomes of cancer patients. For more information, visit www.oncothyreon.com.
SOURCE Oncothyreon Inc.
More by this Source
Oncothyreon Announces Data for L-BLP25 and PX-866 to be Presented at American Society of Clinical Oncology Meeting
May 16, 2013, 06:00 ET
Oncothyreon Reports First Quarter 2013 Financial Results
May 09, 2013, 16:05 ET
Oncothyreon Announces First Quarter 2013 Financial Results Conference Call
May 02, 2013, 08:00 ET
Featured Video
Journalists and Bloggers
Visit PR Newswire for Journalists for releases, photos, ProfNet experts, and customized feeds just for Media.
View and download archived video content distributed by MultiVu on The Digital Center.
Custom Packages
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.